Sponsor of the Day:
Jerkmate
https://www.pharmavoice.com/news/amylyx-obesity-drug-pharma-als-bariatric-bedrosian/807702/
Amylyx pins its next hopes on a niche drug in the obesity space | PharmaVoice
A lot is riding on Amylyx’s late-stage candidate for post-bariatric hypoglycemia.
space pharmavoiceamylyxpinsnexthopes
https://www.pharmavoice.com/news/a-new-delivery-method-muscling-its-way-into-the-rna-space/699050/
A new delivery method muscling its way into the RNA space | PharmaVoice
With an AOC platform targeting muscle diseases, Avidity Biosciences hopes to break open the possibilities of RNA.
new deliveryspace pharmavoicemethodmusclingway
https://www.pharmavoice.com/news/sanofi-multiple-sclerosis-btk-inhibitor-troubles/809242/
What Sanofi’s multiple sclerosis troubles could mean for the space | PharmaVoice
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug class.
multiple sclerosiscould meanspace pharmavoicetroubles